Tyra biosciences may have broken securities laws and impacted stakeholders are urged to lend a hand to the schall law firm's inquiry

Los angeles, ca / accesswire / august 30, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of tyra biosciences, inc. ("tyra" or "the company") (nasdaq:tyra) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
TYRA Ratings Summary
TYRA Quant Ranking